Global Medical REIT (NYSE:GMRE – Get Free Report) is expected to be announcing its Q4 2025 results after the market closes on Wednesday, February 25th. Analysts expect the company to announce earnings of $1.02 per share and revenue of $37.4420 million for the quarter. Investors can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Thursday, February 26, 2026 at 9:00 AM ET.
Global Medical REIT Stock Performance
NYSE GMRE opened at $35.96 on Tuesday. The stock has a market capitalization of $482.22 million, a price-to-earnings ratio of -143.84 and a beta of 1.18. The business’s 50 day moving average is $35.17 and its two-hundred day moving average is $34.33. Global Medical REIT has a 12-month low of $29.05 and a 12-month high of $45.75. The company has a current ratio of 0.52, a quick ratio of 0.52 and a debt-to-equity ratio of 1.65.
Global Medical REIT Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, January 9th. Investors of record on Friday, December 19th were issued a dividend of $0.75 per share. The ex-dividend date of this dividend was Friday, December 19th. This represents a $3.00 annualized dividend and a yield of 8.3%. Global Medical REIT’s payout ratio is currently -1,200.00%.
Institutional Trading of Global Medical REIT
Wall Street Analyst Weigh In
GMRE has been the subject of several recent research reports. Robert W. Baird dropped their price target on Global Medical REIT from $45.00 to $41.00 and set a “neutral” rating for the company in a research report on Tuesday, November 11th. Wall Street Zen lowered Global Medical REIT from a “hold” rating to a “sell” rating in a research note on Saturday, November 8th. Finally, Weiss Ratings raised shares of Global Medical REIT from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, January 21st. One analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $42.00.
Read Our Latest Stock Analysis on Global Medical REIT
About Global Medical REIT
Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.
Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.
Featured Articles
- Five stocks we like better than Global Medical REIT
- Elon Musk already made me a “wealthy man”
- Elon’s Secret AI Partner?
- Elon Musk: This Could Turn $100 into $100,000
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.
